Rezultati - Linnea Chap
- Showing 1 - 6 results of 6
-
1
-
2
A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors od Komal Jhaveri, Kathy D. Miller, Lee S. Rosen, Bryan P. Schneider, Linnea Chap, Alison L. Hannah, Ziyang Zhong, Weining Ma, Clifford A. Hudis, Shanu Modi
Izdano 2012Artigo -
3
Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients od John A. Glaspy, Elizabeth J. Shpall, C.F. LeMaistre, Robert Briddell, Dora Menchaca, Stewart A. Turner, Michael Lill, Linnea Chap, Rena R. Jones, M.D. Wiers, William Sheridan, IK McNiece
Izdano 1997Artigo -
4
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer od Kathy D. Miller, Linnea Chap, Frankie A. Holmes, Melody A. Cobleigh, P. Kelly Marcom, Louis Fehrenbacher, Maura N. Dickler, Beth Overmoyer, James D. Reimann, Amy P. Sing, Virginia K. Langmuir, Hope S. Rugo
Izdano 2005Artigo -
5
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib od R. Charles Coombes, Sacha J. Howell, Simon Lord, Laura Kenny, Janine Mansi, Zahi Mitri, Carlo Palmieri, Linnea Chap, Paul Richards, William J. Gradishar, Sagar Sardesai, Jason Melear, Joyce O’Shaughnessy, Patrick J. Ward, Pavani Chalasani, Hendrik‐Tobias Arkenau, Richard D. Baird, Rinath Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew Krebs
Izdano 2023Artigo -
6
Adjuvant Docetaxel for Node-Positive Breast Cancer od Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, Marek Pawlicki, Jean‐Paul Guastalla, Charles H. Weaver, Eva Tomiak, Taher Al‐Tweigeri, Linnea Chap, É Juhos, R. Guévin, Anthony Howell, Tommy� Fornander, John D. Hainsworth, Robert E. Coleman, J. Vinholes, Manuel Modiano, Tamás Pintér, Shou Ching Tang, Bruce Colwell, Catherine Prady, Louise Provencher, David Walde, Álvaro Rodríguez-Lescure, Judith Hugh, Camille Loret, Matthieu Rupin, Sandra Blitz, Philip Jacobs, M Murawsky, A. Riva, Charles L. Vogel
Izdano 2005Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Breast cancer
Cancer
Oncology
Adverse effect
Chemotherapy
Gastroenterology
Metastatic breast cancer
Bevacizumab
Nausea
Pharmacodynamics
Pharmacokinetics
Pharmacology
Tolerability
Trastuzumab
Adjuvant
Biology
CD34
Cancer research
Capecitabine
Clinical endpoint
Colorectal cancer
Common Terminology Criteria for Adverse Events
Confidence interval
Diarrhea
Docetaxel
Environmental health
Epidermal growth factor receptor
Estrogen receptor